This site is intended for UK Healthcare Professionals only

cardiovascular disease

semaglutide-1280

Increased access to Wegovy is welcome but Labour can go further, say pharmacy bodies

NICE recommended that Wegovy is made available on the NHS to people with cardiovascular disease.

01 Apr 2026

mens-lead

Category update: Breaking down the barriers in men

Men are still reluctant to seek advice about their health, which means early warning signs are often overlooked. Sarah Purcell explores how pharmacy teams can make a difference.

21 Jan 2025

man-clutching-heart

First prescriptions: lipid management

This CPD module covers the management of cardiovascular risk through lipid (cholesterol) lowering medication.

29 Jul 2024

old man smoking.jpg

No smoking: no brainer

Smoking may increase the risk of dementia and cognitive decline by undermining lung function and increasing the likelihood of respiratory and cardiovascular disease.

12 Jan 2023

shingles.jpg

Shingles increases CV risk

An American study of 205,030 people reports that herpes zoster (HZ) increases the risk of a major cardiovascular event by almost 30 per cent

15 Dec 2022

bloods summary.jpg

NICE says 400,000 people could benefit from new triglyceride drug

Vazkepa can reduce heart attack and stroke in individuals with residual risk despite statin treatment.

14 Jun 2022

men cartoon.jpg

Man to man

Highlighting key areas of men's health pharmacy staff can support.

22 Mar 2022

heart, CVD 1_s.jpg

Metabolic syndrome and the link to skin diseases

Patients with inflammatory skin diseases should be targeted and provided with heart health checks by community pharmacy teams.

26 Aug 2020

statin-CVD-heart-disease-blood-pressure-summary.jpg

Value of statins in the elderly confirmed

Starting statins reduces the risk of all-cause and cardiovascular mortality among people aged 75 years and older, a new study finds. 

17 Aug 2020

flu-jab-vaccination-injection.jpg

NHS to trial anti-cholesterol jab in pioneering collaboration with Novartis

NHS will conduct trials of as yet unlicensed inclisiran in bid to cut deaths from heart disease.

15 Jan 2020

Change privacy settings